Baroreflex activation therapy in patients with end-stage renal failure: proof of concept

Journal of Hypertension
Joachim BeigeManuel Wallbach

Abstract

Resistant arterial hypertension and chronic kidney disease (CKD) are interlinked via sympathetic overactivity. Baroreflex activation therapy (BAT) is a well tolerated therapy, which has been shown to reduce BP in patients with resistant hypertension. The effects of BAT in patients with resistant hypertension and end stage renal disease have not been reported. We retrospectively analyzed procedural effectiveness and safety in seven CKD stage 5D patients with resistant hypertension who underwent BAT. One year after activation, office SBP decreased significantly from 194 ± 28 to 137 ± 16 mmHg (P < 0.01). Ambulatory SBP showed a trend to be decreased from 167 ± 30 to 137 ± 24 mmHg (P = 0.17), whereas the median number of prescribed antihypertensive classes decreased from 5 (4-9) to 3 (1-4) (P = 0.01). Intraoperative drop of SBP was -34.3 ± 34.4 mmHg (P = 0.04). With respect to adverse events there were minor side-effects (mainly paresthesia and dysphagia) reported in our patients, which occurred according to treatment intensity and modality. BAT is an effective and well tolerated intervention to reduce BP in patients suffering from end-stage renal disease and resistant hypertension. Therefore, BAT might contribute to a reduction of...Continue Reading

References

Jan 10, 1993·The New England Journal of Medicine·R L ConverseR G Victor
Dec 6, 2003·Hypertension·Aram V ChobanianUNKNOWN National High Blood Pressure Education Program Coordinating Committee
Jul 15, 2004·Seminars in Dialysis·Peter J Blankestijn, Gerry Ligtenberg
Aug 26, 2004·Kidney International·Flavio M de PaulaSergio F F Santos
Jan 18, 2007·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·J H M TordoirR Cody
Sep 4, 2008·Current Hypertension Reports·Ronald G Victor, Moiz M Shafiq
Jan 9, 2010·Clinical Journal of the American Society of Nephrology : CJASN·Allan J CollinsShu-Chen Chen
Mar 30, 2012·Current Hypertension Reports·Michael DoumasVasilios Papademetriou
Nov 30, 2012·Clinical and Experimental Nephrology·Radovan VaskoMichael J Koziolek
Aug 3, 2013·Current Vascular Pharmacology·Guido GrassiGiuseppe Mancia
Jan 9, 2014·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Rajiv AgarwalGetachew G Tegegne
Apr 1, 2014·The New England Journal of Medicine·Deepak L BhattUNKNOWN SYMPLICITY HTN-3 Investigators
Apr 23, 2014·American Journal of Nephrology·Eduardo VázquezJuan Carlos Fernandez-Guerrero
Jul 17, 2014·Kidney International Supplements·Mehmet Ozkahya
Nov 2, 2014·American Journal of Nephrology·Manuel WallbachMichael J Koziolek

❮ Previous
Next ❯

Citations

Jan 10, 2018·Cerebrovascular Diseases·Stefana Catalina BilhaAdrian Covic
Nov 15, 2017·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Manuel Wallbach, Michael J Koziolek
Mar 14, 2020·Current Hypertension Reports·Eline H Groenland, Wilko Spiering
May 16, 2018·Frontiers in Physiology·Ionut TudoranceaRadu Iliescu
Feb 14, 2020·Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society·Marcel HalbachHannes Reuter
Feb 8, 2020·Current Hypertension Reports·Mortimer GierthmuehlenJosef Zentner

❮ Previous
Next ❯

Software Mentioned

Excel
SPSS

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.